ARCHIVES

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

January 31, 2014

Abstract Of Papers Presented By Breast Cancer Task Force

September 24, 1976